动态CZT显像在射血分数保留的心力衰竭中的预后作用
研究纳入112例非阻塞性冠心病患者,基线行动态CZT-SPECT、超声心动图和冠状动脉CT血管造影,随访12个月。MFR≤1.62和NT-proBNP≥760.5 pg/mL是不良心衰进展的独立预测因素。
要点
- MFR≤1.62是非阻塞性冠心病患者HFpEF不良结局的独立预测因素(OR 2.801)。
- NT-proBNP≥760.5 pg/mL亦为独立预测因素(OR 1.87)。
- 动态CZT显像获得的MFR可用于HFpEF风险分层。
核心结论
- 动态CZT显像获得的MFR≤1.62和NT-proBNP≥760.5 pg/mL可识别12个月随访期间HFpEF发生和进展高风险患者,独立于基线临床参数和影像变量。
研究设计与样本
- 研究纳入112例非阻塞性冠心病患者(70例男性;中位年龄62.5[57.0;69.0]岁),基线行动态CZT-SPECT、超声心动图和冠状动脉CT血管造影,随访12个月。
主要发现
- 按不良事件分组:组1为有不良结局患者(n=25),组2为无不良结局患者(n=87)。
- ROC分析确定预测不良结局的截断值:MFR≤1.62(AUC 0.884;P<0.001)、负荷MBF≤1.35 mL/min/g(AUC 0.750;P<0.001)、NT-proBNP≥760.5 pg/mL(AUC 0.764;P=0.001)。
- 单因素分析显示2型糖尿病(P=0.044)、MFR≤1.62(P=0.014)、负荷MBF≤1.35 mL/min/g(P=0.012)、NT-proBNP≥760.5 pg/mL(P=0.018)和舒张功能障碍(P=0.009)是HFpEF发生和进展的潜在危险因素。
- 多因素分析显示NT-proBNP≥760.5 pg/mL(OR 1.87;95%CI 1.17-3.62;P=0.027)和MFR≤1.62(OR 2.801;95%CI 1.19-6.55;P=0.018)是不良结局的独立预测因素。
关键数值与推荐
- MFR≤1.62预测不良结局的AUC为0.884(P<0.001)。
- 负荷MBF≤1.35 mL/min/g预测不良结局的AUC为0.750(P<0.001)。
- NT-proBNP≥760.5 pg/mL预测不良结局的AUC为0.764(P=0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of the study was to evaluate the prognostic role of myocardial flow reserve (MFR) and myocardial blood flow (MBF) estimates obtained with dynamic cadmium-zinc-telluride (CZT) imaging in the development and progression of heart failure with preserved ejection fraction (HFpEF) in patients with nonobstructive coronary artery disease (CAD) during a 12-month follow-up period. PATIENTS AND METHODS: A total of 112 patients (70 men; median age of 62.5 [57.0; 69.0] years) with nonobstructive coronary artery disease were enrolled in the study. Dynamic CZT-SPECT, echocardiography, and coronary CT angiography studies were performed baseline. RESULTS: Distribution of patients was performed by adverse events: group 1 comprised patients with adverse outcomes (n = 25), and group 2 comprised those without it (n = 87). Based on receiver operating characteristic analysis, the levels of MFR ≤1.62 (area under the curve [AUС], 0.884; Р < 0.001), stress-MBF ≤1.35 mL/min per gram (AUС, 0.750; Р < 0.001), and NT-proBNP ≥760.5 pg/mL (AUС, 0.764; Р = 0.001) were identified as cutoff values to predict adverse outcomes. Univariate analysis revealed that type 2 diabetes mellitus ( P = 0.044), the levels of MFR ≤1.62 ( P = 0.014), stress-MBF ≤1.35 mL/min per gram ( P = 0.012), NT-proBNP ≥760.5 pg/mL ( P = 0.018), and diastolic dysfunction ( P = 0.009) were potential risk factors for the development and progression of HFpEF. Multivariate analysis demonstrated that the values of NT-proBNP ≥760.5 pg/mL (odds ratio, 1.87; 95% confidence interval, 1.17-3.62; P = 0.027) and MFR ≤1.62 (odds ratio, 2.801; 95% confidence interval, 1.19-6.55; P = 0.018) were independent predictors of adverse outcomes. CONCLUSIONS: Our data suggest that reduced MFR ≤1.62 obtained with dynamic CZT imaging and overexpression of NT-proBNP ≥760.5 pg/mL can individuate patients at high risk of development and progression of HFpEF during a 12-month follow-up period, independently of baseline clinical parameters and imaging variables.
引用
- Kopeva KV, Mochula AV, Maltseva AN, et al. Prognostic Role of Dynamic CZT Imaging in Heart Failure With Preserved Ejection Fraction. Clin Nucl Med. 2023. PMID: 37290425. doi:10.1097/RLU.0000000000004738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。